Evaluation of the CIHR Clinical Trials Network in HIV/AIDS Program – Long descriptions
Figure 1: Average ARIF and ARC of publications in the field of HIV/AIDS for CTN and top 10 leading countries (2008-2011)
Country | ARIF | ARC |
---|---|---|
Brazil | 0.87 | 0.86 |
Italy | 1.19 | 1.31 |
United States | 1.30 | 1.49 |
Spain | 1.15 | 1.49 |
France | 1.30 | 1.51 |
Australia | 1.24 | 1.58 |
Germany | 1.25 | 1.62 |
Canada | 1.35 | 1.73 |
United Kingdom | 1.35 | 1.75 |
South Africa | 1.37 | 1.89 |
CTN | 1.69 | 2.00 |
Figure 2: Extent to which the CTN contributes to creating new knowledge, all survey groups (N=67)
Investigator | Postdoctural | Community | Total | % | |
---|---|---|---|---|---|
To a great extent | 10 | 12 | 11 | 33 | 49% |
To a moderate extent | 11 | 3 | 8 | 22 | 33% |
To some extent | 5 | 2 | 7 | 10% | |
To a little extent | 3 | 3 | 4% | ||
Don't know | 2 | 2 | 3% | ||
Total | 31 | 17 | 19 | 67 |
Figure 3: Extent to which the CTN contributes to translating the knowledge from research into real world applications, N=67
Investigator | Postdoctural | Community | Total | % | |
---|---|---|---|---|---|
To a great extent | 7 | 9 | 10 | 26 | 39% |
To a moderate extent | 10 | 5 | 8 | 23 | 34% |
To some extent | 7 | 3 | 1 | 11 | 16% |
To a little extent | 4 | 0 | 0 | 4 | 6% |
Not at all | 1 | 0 | 0 | 1 | 1% |
Don't know | 2 | 0 | 0 | 2 | 3% |
Total | 31 | 17 | 19 | 67 |
Figure 4: The CTN is positioned as a global leader
Investigator | Postdoctural | Community | Total | % | |
---|---|---|---|---|---|
Strongly agree | 5 | 6 | 11 | 22 | 33% |
Agree | 16 | 9 | 5 | 30 | 45% |
Neutral | 5 | 2 | 3 | 10 | 15% |
Strongly disagree | 3 | 3 | 4% | ||
Don't know | 1 | 1 | 1% | ||
Not applicable | 1 | 1 | 1% | ||
Total | 31 | 17 | 19 | 67 |
Figure 5: Present Positions CTN Postdoctoral Fellowship Awardees From 1992 to 2012, N=59
Position | Number of awardees |
---|---|
Fellow | 11 |
Student | 2 |
Academia | 29 |
Doctor | 17 |
Private Industry | 5 |
Figure 6: CTN Postdoctoral Fellowship Awardees from 1992 to 2012 (N=59) Who Have a Record with CIHR
Position | Number of awardees |
---|---|
Principal investigator | 15 |
Co-investigator | 21 |
Current application submitted | 20 |
CIHR peer review member | 5 |
Figure 7: Perceived role of influence of partners, community members and affiliated investigators
Perceived role of influence | Strongly agree or agree |
---|---|
Affiliated investigators have an active and influential role in the CTN. | 79% |
Community members have an active and influential role in the CTN. | 85% |
Partners (community, agency, AIDS Service Organizations, etc.) have an active and influential role in the CTN. | 68% |
Figure 8: Inter-institutional collaboration rate of publications in the field of HIV/AIDS for CTN, top 10 countries
Country | 2001-2007 | 2008-2011 |
---|---|---|
CTN | 83% | 91% |
France | 56% | 65% |
United States | 53% | 56% |
Brazil | 52% | 55% |
Canada | 50% | 54% |
Italy | 50% | 53% |
Australia | 49% | 52% |
Spain | 41% | 58% |
South Africa | 38% | 44% |
United Kingdom | 33% | 38% |
Germany | 35% | 37% |
Figure 10 - Investigator and postdoctoral survey respondents satisfaction and use of CTN services, N=31
Usage | Satisfaction | |
---|---|---|
Study Planning | 84% | 58% |
Study Implementation | 74% | 55% |
Liaisons & Communications | 77% | 61% |
Funding Support | 87% | 58% |
- Date modified: